Back to calendar
Ligand Pharmaceuticals Incorporated (LGND) Earnings
LGND reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026
Q2 2026
Est. EPS: $2.35
Actual EPS: $2.37
EPS surprise: 17.92%
Company overview
Market Cap$5.8B
PriceUSD 291.67
P/E31.18
EPS (TTM)9.35
52-week high326.63
52-week low149.51
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees47